Jitesh Nandalal Keni

Jitesh Nandalal Keni

Active Director Director DIN 09354903
DIN 09354903 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Jitesh Nandalal Keni

Data last updated:

Jitesh Nandalal Keni is a Director at Niitrochem Pharma Private Limited (since 2021). The company operates in Chemicals. Niitrochem Pharma Private Limited reported revenue of ₹54.4 Lakh (FY 2025).

DIN 09354903
Primary Designation Director
Industry Chemicals
First Appointment 13 Oct 2021
Oldest Company Age 5 yrs
Largest company Niitrochem Pharma Private Limited · ₹54.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Niitrochem Pharma Private Limited U24299MH2021PTC364205
Director13 Oct 20212021₹54.4 Lakh (FY 2025)Active

Board colleagues of Jitesh Nandalal Keni

NameDINCompanyDesignation
Pritish Sadanand Palekar09246117Niitrochem Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Niitrochem Pharma Private Limited
Premium access

Shareholding and investment profile for Jitesh Nandalal Keni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitesh Nandalal Keni

Jitesh Nandalal Keni currently holds 1 directorship: Niitrochem Pharma Private Limited (Director, since 13 Oct 2021, revenue ₹54.4 Lakh (FY 2025)).

Jitesh Nandalal Keni was first appointed on 13 Oct 2021 as Director at Niitrochem Pharma Private Limited.

The current boards of Jitesh Nandalal Keni's companies include Pritish Sadanand Palekar (Niitrochem Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available